Scarica l'app Stockscreener
1.12
7.44%
-0.09
Precedente Chiudi:
$1.21
Aprire:
$1.21
Volume 24 ore:
20,627
Relative Volume:
0.44
Capitalizzazione di mercato:
$7.33M
Reddito:
$500.00K
Utile/perdita netta:
$-9.78M
Rapporto P/E:
-0.7264
EPS:
-1.5419
Flusso di cassa netto:
$-8.10M
1 W Prestazione:
+12.00%
1M Prestazione:
-14.50%
6M Prestazione:
-71.69%
1 anno Prestazione:
-78.00%
Intervallo 1D:
$1.10
$1.24
Intervallo di 1 settimana:
$0.936
$1.26
Portata 52W:
$0.936
$9.4799
Exicure Inc Stock (XCUR) Company Profile
Nome
Exicure Inc
Settore
Industria
Telefono
847-673-1707
Indirizzo
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XCUR
Exicure Inc
|
1.12 | 7.33M | 500.00K | -9.78M | -8.10M | -1.5419 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-12-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2020-12-18 | Iniziato | BMO Capital Markets | Outperform |
| 2019-11-20 | Iniziato | Guggenheim | Buy |
Exicure Inc Borsa (XCUR) Ultime notizie
Exicure Gets Nasdaq Extension as Delisting Risk Persists - MyChesCo
Cyngn Inc.Common stock (NQ: CYN - The Chronicle-Journal
Exicure Inc (NASDAQ: XCUR) Share Price, XCUR Stock News, XCUR Share Price & Updates - kalkine.ca
Nasdaq gives Exicure until Dec. 2 to show it has $2.5 million left after debts - Stock Titan
Free cash flow of Exicure, Inc. – HAM:2H0 - TradingView
Cash flow from investing activities of Exicure, Inc. – HAM:2H0 - TradingView
Total common shares outstanding of Exicure, Inc. – HAM:2H0 - TradingView
Return on assets % of Exicure, Inc. – HAM:2H0 - TradingView
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - Barchart.com
Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the RangeRounding Top - vinanet.vn
Exicure (XCUR) Price: Declines 11.54% to $1.15 in the Latest Reading; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range for the Current SessionEqual Weight ETF - vinanet.vn
Exicure (XCUR) Quarterly Figures: EPS Comes in Below Forecast for This Review; Share Response: The Stock Ends Down 10.34% for the Current SessionGuidance Update - vinanet.vn
Exicure Stock Price Forecast. Should You Buy XCUR? - StockInvest.us
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView
Exicure Deadline Alert - TMX Newsfile
Exicure Update - TMX Newsfile
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Inc (XCUR) Stock News Today - TradingKey
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Weighs on SharesCFO Commentary Report - vinanet.vn
Trading Systems Reacting to (XCUR) Volatility - Stock Traders Daily
Exicure Shareholder Alert - TMX Newsfile
XCUR Looks 231.6% Overvalued on GF Value™ - GuruFocus
Exicure to issue shares to settle $1M clinical milestone payment - Investing.com
Exicure to issue shares to settle $1M clinical milestone payment By Investing.com - Investing.com Nigeria
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - The Manila Times
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - Yahoo Finance Singapore
XCUR Q2 2022 Earnings: EPS Misses by 35.6% as No Revenue ReportedDividend Cut Risk - vinanet.vn
Exicure Inc. (XCUR) Rises 4.46% to $1.64 as Shares Approach Key Resistance LevelETF Creation Redemption - vinanet.vn
Exicure Shareholder Alert - TMX Newsfile
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Exicure Inc (XCUR) Cash Flow - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Balance Sheet - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XCUR|Exicure Inc|Price:1.330|Chg%:-0.180 - TradingKey
XCUR|Exicure Inc|Price:1.750|Chg%:-0.010 - TradingKey
XCUR|Exicure Inc|Price:1.760|Chg%:+0.050 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates Amid Development ChallengesGuidance Revision Trend - vinanet.vn
Exicure Inc (XCUR) Income Statement - TradingKey
Exicure, Inc. Revenue Breakdown – NASDAQ:XCUR - TradingView
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XCUR stock trades on limited evidence as Exicure waits for filings - Ad-hoc-news.de
XCUR|Exicure Inc|Price:1.700|Chg%:-0.010 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates, Stock Declines as Pre-Revenue Biotech Faces ChallengesOperating Margin Analysis - vinanet.vn
Form 4 Exicure Inc For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc. (XCUR) Q2 2022 Earnings: EPS Misses Estimates Significantly, Stock Rises 3.7%Earnings Decline Risk - vinanet.vn
Form 13D/A EXICURE For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc Azioni (XCUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Exicure Inc Azioni (XCUR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Exicure HiTron Inc. | 10% Owner |
Jan 16 '26 |
Sale |
4.50 |
734,747 |
3,306,362 |
1,857,314 |
| Exicure HiTron Inc. | 10% Owner |
Jan 07 '26 |
Sale |
4.50 |
741,272 |
3,335,724 |
2,592,061 |
| SANGSANGIN INVESTMENT & SECURI | 10% Owner |
Dec 08 '25 |
Sale |
8.71 |
433,332 |
3,774,322 |
0 |
1.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):